Westerkirk Capital »

Edwards Lifesciences shares owned by Westerkirk Capital

Quarter-by-quarter ownership of Edwards Lifesciences (EW) shares owned by Westerkirk Capital from 13F filings

Historical chart of Westerkirk Capital investment in Edwards Lifesciences

Tip: Access up to 7 years of quarterly data

All positions including Edwards Lifesciences held by Westerkirk Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edwards Lifesciences by Westerkirk Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $443k 5.7k 77.77
2025-06-30 $493k 6.3k 78.21

More positions owned by Westerkirk Capital

Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Mastercard Incorporated Cl A (MA)
Meta Platforms Cl A (META)
Visa Com Cl A (V)
Alphabet Cap Stk Cl C (GOOG)
Netflix (NFLX)
Alphabet Cap Stk Cl A (GOOGL)
TJX Companies (TJX)
Canadian Pacific Kansas City (CP)

View all positions for Westerkirk Capital

Top funds holding Edwards Lifesciences

Vanguard Group
BlackRock
State Street Corporation
Jpmorgan Chase & Co
Wellington Management Company
Bank of New York Mellon
FMR
Jennison Associates
Geode Capital Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Investec Asset Management
Morgan Stanley
Brown Advisory Holdings Incorporated
Deutsche Bank Aktiengesellschaft
Northern Trust

View all funds holding Edwards Lifesciences